Update shared on10 Aug 2025
Fair value Decreased 21%Despite improved revenue growth forecasts and a substantially lower forward P/E, Sylvamo's consensus analyst price target has fallen from $68.33 to $61.67, indicating valuation concerns outweigh modestly better fundamentals.
What's in the News
- Sylvamo Corporation added to Russell 2000 Growth-Defensive Index.
- Sylvamo Corporation added to Russell 2000 Defensive Index.
- Sylvamo Corporation added to Russell 2000 Value-Defensive Index.
- Board of Directors adopted second amended and restated by-laws, revising advance notice procedures for director nominations and business proposals, clarifying majority voting and contested elections, specifying Board's ability to propose business at special stockholder meetings, and making administrative and legal updates.
Valuation Changes
Summary of Valuation Changes for Sylvamo
- The Consensus Analyst Price Target has fallen from $68.33 to $61.67.
- The Consensus Revenue Growth forecasts for Sylvamo has significantly risen from -2.8% per annum to -1.1% per annum.
- The Future P/E for Sylvamo has significantly fallen from 15.03x to 10.74x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.